KRASC - Overview: KRAS Mutation Analysis, 7 Mutation Panel, Colorectal

Test Catalog

Test Name

Test ID: KRASC    
KRAS Mutation Analysis, 7 Mutation Panel, Colorectal

Useful For Suggests clinical disorders or settings where the test may be helpful

Prognostic markers for cancer patients treated with epidermal growth factor receptor-targeted therapies

Additional Tests Lists tests that are always performed, at an additional charge, with the initial tests

Test IDReporting NameAvailable SeparatelyAlways Performed
SLIRVSlide Review in MGNo, (Bill Only)Yes

Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

When this test is ordered, slide review will always be performed at an additional charge.

Special Instructions and Forms Library of PDFs including pertinent information and consent forms, specimen collection and preparation information, test algorithms, and other information pertinent to test

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR) Analysis

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Reporting Name A shorter or abbreviated version of the Published Name for a test; an abbreviated test name

KRAS Mutation Analysis, Colorectal

Aliases Lists additional common names for a test, as an aid in searching

Cetuximab (Erbitux)
Erbitux (Cetuximab)
Patiumumab (Vectibix)
Vectibix (Patiumumab)